REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmaway Sp. z o.o. (Poland)

Main Activities: Advertising Agencies
Full name: Pharmaway Sp. z o.o. Profile Updated: May 13, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Pharmaway Sp. z o.o. is based in Poland. The head office is in Krakow. The enterprise operates in the Advertising Agencies industry. The company was established on May 06, 2021. From the latest financial highlights, Pharmaway Sp. z o.o. reported a net sales revenue increase of 2.14% in 2023. Over the same period, its total assets grew by 19.06%. The net profit margin of Pharmaway Sp. z o.o. decreased by 22.31% in 2023.

Headquarters
Ul. Wladyslawa Syrokomli 23/2
Krakow; Malopolskie; Postal Code: 30-102

Contact Details: Purchase the Pharmaway Sp. z o.o. report to view the information.

Website: http://www.pharmaway.pl

Basic Information
Outstanding Shares:
Purchase the Pharmaway Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Pharmaway Sp. z o.o. report to view the information.
Incorporation Date:
May 06, 2021
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
95%
Company Performance
Financial values in the chart are available after Pharmaway Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
2.14%
Total operating revenue
2.02%
Operating profit (EBIT)
-67.97%
Net Profit (Loss) for the Period
-67.63%
Total assets
19.06%
Total equity
24.21%
Operating Profit Margin (ROS)
-24.78%
Net Profit Margin
-22.31%
Return on Equity (ROE)
-55.29%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?